Hepatocellular Carcinoma: An In-Depth Look at Local and Systemic Therapies CME

Ghassan K. Abou-Alfa, MD, Chair; Josep M. Llovet, MD; Lawrence H. Schwartz, MD Author Information and Disclosures

Release Date: April 4, 2008; Valid for credit through April 4, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

This CME activity is based on transcripts and slides presented by faculty at the "Hepatocellular Carcinoma: An In-Depth Look at Local and Systemic Therapies" symposium held at the Orlando World Center Marriott in Orlando, Florida, on January 26, 2008.

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the educational content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 SciMed
Bayer, Onyx
Learning Objectives
Upon completion of this activity, participants should be able to:
  1. Discuss the challenges and limitations of nonsurgical strategies for the management of patients with HCC.
  2. Evaluate the clinical evidence to date for targeted therapies as single agents and in combination with standard chemotherapies in patients with advanced HCC, and assess their effect on tumor necrosis and delay in symptomatic progression.
  3. Identify the limitations of current radiologic evaluations in assessing disease, and describe novel dynamic approaches for assessing response.
Author Disclosures
Ghassan K. Abou-Alfa, MD, Chair
Disclosure: Grants/Research Support: Bayer HealthCare Pharmaceuticals

Josep M. Llovet, MD
Disclosure: Grants/Research Support: Bayer HealthCare Pharmaceuticals; Consultant: Bayer HealthCare Pharmaceuticals, Biocompatibles, MDS Nordion

Lawrence H. Schwartz, MD
Disclosure: Grants/Research Support: GE Medical Systems, Novartis

All SciMed personnel involved in the development of content for this activity have no relevant conflicts to report.

The materials for this activity were peer reviewed and the reviewer had no relevant conflicts to report.
 
SciMed is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SciMed designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.